06 May 2021
Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.
07 April 2021
The connection of the Novo Nordisk® smart insulin pens with the mySugr Logbook is now available on iOS in the first country Sweden, with more markets to follow. Bringing data together and setting it into context provides patients and healthcare professionals with a broader picture of the individual diabetes therapy and aims to support its optimization.
01 March 2021
Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop
The Accu-Chek Insight insulin pump from Roche will be the first pump with a pre-filled cartridge that can be operated in loop mode. As part of DBLG1 System from Diabeloop, the Accu-Chek Insight insulin pump will enable people with diabetes to better manage their diabetes and improve their time in range.
11 December 2020
The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes. By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche’s strategy of integrated Personalised Diabetes Management (iPDM).
21 September 2020
Roche introduces a Remote Patient Monitoring solution at the 56th Annual Meeting of the European Association for the Study of Diabetes
The Remote Patient Monitoring solution is an element of the RocheDiabetes Care Platform helping healthcare professionals to provide care when and where it is needed, thus enabling a more efficient and personalised approach to diabetes care.